Director of Autism Research, Arkansas Children's Hospital Research Institute
Appears in 1 story
Leading researcher on leucovorin and autism; continues to advocate for further study
In September 2025, White House officials told parents of autistic children that a cheap, generic drug called leucovorin might improve their children's speech and behavior. Prescriptions surged 71% in the following months, pharmacies ran dry, and the Food and Drug Administration (FDA) allowed emergency imports from Canada and Spain. On March 10, 2026, the FDA approved leucovorin — but only for a genetic condition so rare that fewer than 50 cases have ever been identified worldwide, not for autism.
Updated 7 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
